Freestone Grove Partners »

Newamsterdam Pharma Co Nv shares owned by Freestone Grove Partners

Quarter-by-quarter ownership of Newamsterdam Pharma Co Nv (NAMS) shares owned by Freestone Grove Partners from 13F filings

Historical chart of Freestone Grove Partners investment in Newamsterdam Pharma Co Nv

Tip: Access up to 7 years of quarterly data

All positions including Newamsterdam Pharma Co Nv held by Freestone Grove Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Newamsterdam Pharma Co Nv by Freestone Grove Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $96k 3.0k 32.01

More positions owned by Freestone Grove Partners

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Core S&p500 Etf (IVV)
State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Johnson & Johnson (JNJ)
Citigroup Com New (C)
Axis Cap Hldgs SHS (AXS)
Datadog Cl A Com (DDOG)
Booz Allen Hamilton Hldg Cor Cl A (BAH)
BP Sponsored Adr (BP)
Elastic N V Ord Shs (ESTC)
Pinnacle Finl Partners (PNFP)
Intuitive Surgical Com New (ISRG)
Dynatrace Com New (DT)
Xcel Energy (XEL)
Mondelez Intl Cl A (MDLZ)

View all positions for Freestone Grove Partners

Top funds holding Newamsterdam Pharma Co Nv

Frazier Life Sciences Management
Capital World Investors
RA Capital Management
Fcpm Iii Services B.v.
Bain Capital Life Sciences Investors
FMR
Wellington Management Company
Deerfield Management Company
Viking Global Investors
Duquesne Family Office
Polar Capital Holdings
Jennison Associates
Medicxi Ventures Management
Henderson Group
Westfield Capital Management Company

View all funds holding Newamsterdam Pharma Co Nv